NGS-based RNA-sequencing Market Size, Share, and Outlook, H2-2025 Report- By Products and Services (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequen
Description
NGS-based RNA-sequencing Market Outlook
The global NGS-based RNA-sequencing Market Size is valued at $4.6 Billion in 2025 and is forecast to reach $14.7 Billion in 2032 at a CAGR of 18.1%.
The NGS-based RNA-sequencing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on NGS-based RNA-sequencing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA-sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
NGS-based RNA-sequencing Market Insights, 2025
The NGS-based RNA-sequencing Market is evolving rapidly with the adoption of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics technologies, enabling unprecedented resolution of gene expression patterns. Recent developments include improved multiplexing capabilities and cost-efficient sequencing chemistries, making RNA-seq more accessible for large-scale studies. Pharmaceutical and biotechnology companies are increasingly using RNA-seq for drug discovery, biomarker identification, and understanding disease mechanisms. AI-driven bioinformatics pipelines are enhancing data interpretation, reducing analysis time from weeks to hours. Moreover, RNA-seq is expanding into clinical diagnostics, particularly in oncology and neurology, with regulatory bodies beginning to recognize its diagnostic potential. Strategic collaborations between sequencing technology providers and clinical research organizations are strengthening market growth.
Five Trends Shaping the Global NGS-based RNA-sequencing Market in 2025 and Beyond
The global NGS-based RNA-sequencing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the NGS-based RNA-sequencing Industry?
The NGS-based RNA-sequencing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, NGS-based RNA-sequencing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
NGS-based RNA-sequencing Market Segment Insights
The NGS-based RNA-sequencing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA-sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
NGS-based RNA-sequencing Industry Value Chain
The chapter identifies potential companies and their operations across the global NGS-based RNA-sequencing Industry ecosystem. It assists decision-makers in evaluating global NGS-based RNA-sequencing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the NGS-based RNA-sequencing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific NGS-based RNA-sequencing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for NGS-based RNA-sequencing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States NGS-based RNA-sequencing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American NGS-based RNA-sequencing Market.
Europe NGS-based RNA-sequencing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for NGS-based RNA-sequencing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for NGS-based RNA-sequencing Industry competitiveness. The report analyses the key NGS-based RNA-sequencing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American NGS-based RNA-sequencing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international NGS-based RNA-sequencing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa NGS-based RNA-sequencing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for NGS-based RNA-sequencing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How NGS-based RNA-sequencing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the NGS-based RNA-sequencing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Agilent Technologies Inc, BGI Group, Eurofins Scientific SE, F. Hoffmann-La Roche AG, GENEWIZ LLC, Hamilton Company, Illumina Inc, Nugen Technologies Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Psomagen Inc, QIAGEN N.V., Takara Bio Inc, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
NGS-based RNA-sequencing Market Scope
Leading Segments
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
Leading Companies
Agilent Technologies Inc
BGI Group
Eurofins Scientific SE
F. Hoffmann-La Roche AG
GENEWIZ LLC
Hamilton Company
Illumina Inc
Nugen Technologies Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global NGS-based RNA-sequencing Market Size is valued at $4.6 Billion in 2025 and is forecast to reach $14.7 Billion in 2032 at a CAGR of 18.1%.
The NGS-based RNA-sequencing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on NGS-based RNA-sequencing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA-sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
NGS-based RNA-sequencing Market Insights, 2025
The NGS-based RNA-sequencing Market is evolving rapidly with the adoption of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics technologies, enabling unprecedented resolution of gene expression patterns. Recent developments include improved multiplexing capabilities and cost-efficient sequencing chemistries, making RNA-seq more accessible for large-scale studies. Pharmaceutical and biotechnology companies are increasingly using RNA-seq for drug discovery, biomarker identification, and understanding disease mechanisms. AI-driven bioinformatics pipelines are enhancing data interpretation, reducing analysis time from weeks to hours. Moreover, RNA-seq is expanding into clinical diagnostics, particularly in oncology and neurology, with regulatory bodies beginning to recognize its diagnostic potential. Strategic collaborations between sequencing technology providers and clinical research organizations are strengthening market growth.
Five Trends Shaping the Global NGS-based RNA-sequencing Market in 2025 and Beyond
The global NGS-based RNA-sequencing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the NGS-based RNA-sequencing Industry?
The NGS-based RNA-sequencing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, NGS-based RNA-sequencing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
NGS-based RNA-sequencing Market Segment Insights
The NGS-based RNA-sequencing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA-sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
NGS-based RNA-sequencing Industry Value Chain
The chapter identifies potential companies and their operations across the global NGS-based RNA-sequencing Industry ecosystem. It assists decision-makers in evaluating global NGS-based RNA-sequencing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the NGS-based RNA-sequencing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific NGS-based RNA-sequencing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for NGS-based RNA-sequencing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States NGS-based RNA-sequencing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American NGS-based RNA-sequencing Market.
Europe NGS-based RNA-sequencing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for NGS-based RNA-sequencing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for NGS-based RNA-sequencing Industry competitiveness. The report analyses the key NGS-based RNA-sequencing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American NGS-based RNA-sequencing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international NGS-based RNA-sequencing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa NGS-based RNA-sequencing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for NGS-based RNA-sequencing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How NGS-based RNA-sequencing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the NGS-based RNA-sequencing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Agilent Technologies Inc, BGI Group, Eurofins Scientific SE, F. Hoffmann-La Roche AG, GENEWIZ LLC, Hamilton Company, Illumina Inc, Nugen Technologies Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Psomagen Inc, QIAGEN N.V., Takara Bio Inc, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
NGS-based RNA-sequencing Market Scope
Leading Segments
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
Leading Companies
Agilent Technologies Inc
BGI Group
Eurofins Scientific SE
F. Hoffmann-La Roche AG
GENEWIZ LLC
Hamilton Company
Illumina Inc
Nugen Technologies Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
190 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 NGS-based RNA-sequencing Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest NGS-based RNA-sequencing Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global NGS-based RNA-sequencing Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 NGS-based RNA-sequencing Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. NGS-based RNA-sequencing Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Products and Services
- Sample Preparation Products
- RNA-sequencing Platforms and Consumables
- RNA-sequencing Services
- Data Analysis
- Storage & Management
- By Technology
- Sequencing By Synthesis
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing
- Nanopore Sequencing
- By Application
- Expression Profiling Analysis
- Small RNA-sequencing
- De Novo Transcriptome Assembly
- Variant Calling and Transcriptome Epigenetics
- By End-User
- Research and Academia
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
- 6. Global NGS-based RNA-sequencing Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America NGS-based RNA-sequencing Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America NGS-based RNA-sequencing Market Trends and Growth Opportunities
- 6.2.1 North America NGS-based RNA-sequencing Market Outlook by Type
- 6.2.2 North America NGS-based RNA-sequencing Market Outlook by Application
- 6.3 North America NGS-based RNA-sequencing Market Outlook by Country
- 6.3.1 The US NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 6.3.2 Canada NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 6.3.3 Mexico NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7. Europe NGS-based RNA-sequencing Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe NGS-based RNA-sequencing Market Trends and Growth Opportunities
- 7.2.1 Europe NGS-based RNA-sequencing Market Outlook by Type
- 7.2.2 Europe NGS-based RNA-sequencing Market Outlook by Application
- 7.3 Europe NGS-based RNA-sequencing Market Outlook by Country
- 7.3.2 Germany NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7.3.3 France NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7.3.4 The UK NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7.3.5 Spain NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7.3.6 Italy NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7.3.7 Russia NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8. Asia Pacific NGS-based RNA-sequencing Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific NGS-based RNA-sequencing Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific NGS-based RNA-sequencing Market Outlook by Type
- 8.2.2 Asia Pacific NGS-based RNA-sequencing Market Outlook by Application
- 8.3 Asia Pacific NGS-based RNA-sequencing Market Outlook by Country
- 8.3.1 China NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8.3.2 India NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8.3.3 Japan NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8.3.4 South Korea NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8.3.5 Australia NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8.3.6 South East Asia NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 9. South America NGS-based RNA-sequencing Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America NGS-based RNA-sequencing Market Trends and Growth Opportunities
- 9.2.1 South America NGS-based RNA-sequencing Market Outlook by Type
- 9.2.2 South America NGS-based RNA-sequencing Market Outlook by Application
- 9.3 South America NGS-based RNA-sequencing Market Outlook by Country
- 9.3.1 Brazil NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 9.3.2 Argentina NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 10. Middle East and Africa NGS-based RNA-sequencing Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa NGS-based RNA-sequencing Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa NGS-based RNA-sequencing Market Outlook by Type
- 10.2.2 Middle East and Africa NGS-based RNA-sequencing Market Outlook by Application
- 10.3 Middle East and Africa NGS-based RNA-sequencing Market Outlook by Country
- 10.3.1 Saudi Arabia NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 10.3.2 The UAE NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 10.3.4 South Africa NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 10.3.5 Egypt NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa NGS-based RNA-sequencing Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Agilent Technologies Inc
- BGI Group
- Eurofins Scientific SE
- F. Hoffmann-La Roche AG
- GENEWIZ LLC
- Hamilton Company
- Illumina Inc
- Nugen Technologies Inc
- Oxford Nanopore Technologies Ltd
- Pacific Biosciences of California Inc
- PerkinElmer Inc
- Psomagen Inc
- QIAGEN N.V.
- Takara Bio Inc
- Thermo Fisher Scientific Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
